scholarly journals Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

2019 ◽  
Vol 104 (6) ◽  
pp. 2367-2374 ◽  
Author(s):  
Segolene Hescot ◽  
Maria Curras-Freixes ◽  
Timo Deutschbein ◽  
Anouk van Berkel ◽  
Delphine Vezzosi ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Malignant Pheochromocytoma ◽  
Adrenal Tumors ◽  
European Network

N-cadherin Expression in Adrenal Tumors: Upregulation in Malignant Pheochromocytoma and Downregulation in Adrenocortical Carcinoma

2002 ◽  
Vol 13 (2) ◽  
pp. 099-110 ◽  
Author(s):  
Amir Khorram-Manesh ◽  
Håkan Ahlman ◽  
Svante Jansson ◽  
Ola Nilsson
Keyword(s):  
Adrenocortical Carcinoma ◽  
Malignant Pheochromocytoma ◽  
Adrenal Tumors

Disorders of the Adrenal Glands

2017 ◽  
Author(s):  
Carolina Martinez ◽  
Kelvin Memeh ◽  
Beatrice Caballero ◽  
Marlon A Guerrero
Keyword(s):  
Key Words ◽  
Adrenal Glands ◽  
Cushing Syndrome ◽  
Malignant Potential ◽  
Malignant Pheochromocytoma ◽  
Adrenal Tumors ◽  
Anatomy And Physiology ◽  
Adrenal Hormone ◽  
Addison Disease ◽  
Conn Syndrome

Adrenal tumors are most commonly identified incidentally during imaging for nonadrenal causes. Others may be identified after a patient presents with symptoms of adrenal hormone excess. Adrenal tumors are categorized as functional or nonfunctional, as well as by their malignant potential. It is important to understand the functionality of adrenal glands and properly diagnose potentially hormonally active adrenal tumors. This review outlines the anatomy and physiology of the adrenal glands and details the management of the diseases that result from adrenal hormone excess. This review contains 8 figures, 7 tables, and 27 references. Key words: Addison disease, adrenal, aldosterone, catecholamine, Conn syndrome, cortisol, Cushing syndrome, function, glucocorticoid, malignant, pheochromocytoma 

The metabolic complications in adrenal tumors: a retrospective study in 56 patients

2013 ◽  
Author(s):  
Catalina Poiana ◽  
Mara Carsote ◽  
Dan Hortopan ◽  
Cristina Corneci ◽  
Adriana Gruia ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Adrenal Tumors ◽  
Metabolic Complications

Disorders of the Adrenal Glands

2017 ◽  
Author(s):  
Carolina Martinez ◽  
Kelvin Memeh ◽  
Beatrice Caballero ◽  
Marlon A Guerrero
Keyword(s):  
Key Words ◽  
Adrenal Glands ◽  
Cushing Syndrome ◽  
Malignant Potential ◽  
Malignant Pheochromocytoma ◽  
Adrenal Tumors ◽  
Anatomy And Physiology ◽  
Adrenal Hormone ◽  
Addison Disease ◽  
Conn Syndrome

Adrenal tumors are most commonly identified incidentally during imaging for nonadrenal causes. Others may be identified after a patient presents with symptoms of adrenal hormone excess. Adrenal tumors are categorized as functional or nonfunctional, as well as by their malignant potential. It is important to understand the functionality of adrenal glands and properly diagnose potentially hormonally active adrenal tumors. This review outlines the anatomy and physiology of the adrenal glands and details the management of the diseases that result from adrenal hormone excess. This review contains 8 figures, 7 tables, and 27 references. Key words: Addison disease, adrenal, aldosterone, catecholamine, Conn syndrome, cortisol, Cushing syndrome, function, glucocorticoid, malignant, pheochromocytoma 

scholarly journals Activity of temozolomide (TMZ) in patients (PTS) with malignant pheochromocytoma or paraganglioma (MPP): A mono-institutional retrospective study

2017 ◽  
Vol 28 ◽  
pp. v156 ◽  
Author(s):  
G. Lombardi ◽  
M.A. Ferrara ◽  
A. Pambuku ◽  
M. Lorusso ◽  
F. Boaretto ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Malignant Pheochromocytoma

scholarly journals Surgical Management of Adrenocortical Carcinoma: Current Highlights

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 909
Author(s):  
Giuseppe Cavallaro ◽  
Mariarita Tarallo ◽  
Ambra Chiappini ◽  
Daniele Crocetti ◽  
Andrea Polistena ◽  
...  
Keyword(s):  
Adrenocortical Carcinoma ◽  
Cochrane Library ◽  
Surgical Approaches ◽  
Adrenal Tumors ◽  
European Network ◽  
Time To Recurrence ◽  
Prisma Statement ◽  
Specific Mortality ◽  
Robotic Adrenalectomy ◽  
Cancer Specific Mortality

Introduction: Adrenocortical carcinoma (ACC) is a rare tumor, often discovered at an advanced stage and associated with poor prognosis. Treatment is guided by staging according to the European Network for the Study of Adrenal Tumors (ENSAT) classification. Surgery is the treatment of choice for ACC. The aim of this review is to provide a complete overview on surgical approaches and management of adrenocortical carcinoma. Methods: This comprehensive review has been carried out according to the PRISMA statement. The literature sources were the databases PubMed, Scopus and Cochrane Library. The search thread was: ((surgery) OR (adrenalectomy)) AND (adrenocortical carcinoma). Results: Among all studies identified, 17 were selected for the review. All of them were retrospective. A total of 2498 patients were included in the studies, of whom 734 were treated by mini-invasive approaches and 1764 patients were treated by open surgery. Conclusions: Surgery is the treatment of choice for ACC. Open adrenalectomy (OA) is defined as the gold standard. In recent years laparoscopic adrenalectomy (LA) has gained more popularity. No significant differences were reported for overall recurrence rate, time to recurrence, and cancer-specific mortality between LA and OA, in particular for Stage I-II. Robotic adrenalectomy (RA) has several advantages compared to LA, but there is still a lack of specific documentation on RA use in ACC.

Sign in / Sign up

Export Citation Format

Share Document